The sarcoma field is small, and the need for fostered collaboration is critical. we can help improve patient outcomes and ultimately
achieve a cure with your support.

HOW CAN YOU BEST HELP?

SARC is dedicated to fostering progress in the treatment of sarcoma to improve patient outcomes and ultimately find a cure.  SARC is one of the few organizations focusing on all types of Ssarcomas.  Please take a moment to read more about SARC’s accomplishments and goals for the future of sarcoma research in our Case Statement for Financial Support.

Download case statement for financial support

WAYS TO GIVE

OPERATIONAL SUPPORT

SARC has been the fortunate recipient of program-related restricted funding, but our ability to continue to operate requires general operating support in the future.  Every dollar donated supports our mission delivery.  Furthermore, 75% of all donations go directly to SARC’s program initiatives, with the remainder supporting all other operational expenses. 

For more information, contact Angel Parry

aparry@sarctrials.org
(734) 930-7600

Events

SARC is proud to partner with individual supporters in various types of events based fundraising efforts. From social media to locally based walk-a-thons, triathlons, and beyond, SARC is grateful for the support of our community and would love to speak with you more about possible event opportunities.

For more information, contact Angel Parry

aparry@sarctrials.org
(734) 930-7600

PROGRAM SUPPORT

SARC supports various programs including focused innovated clinical trials, recruiting and mentoring researchers dedicated to defeating sarcoma, education opportunities for professionals, as well as patient/caregiver advocacy support.

For more information, contact Angel Parry

aparry@sarctrials.org
(734) 930-7600

Planned Giving/Legacy Giving

Planned gifts are donations that are set up now to be donated at a future date. Planned giving donations are usually arranged for after a donor has passed away and can also be referred to as legacy giving. While legacy gifts are often made as a bequest in a donor’s will, they can take other forms as well. This includes gifts of life insurance, charitable annuities, charitable remainder trusts, and gifts of stocks or securities.

For more information, contact Angel Parry

aparry@sarctrials.org
(734) 930-7600

SARC OPERATIonal SUPPORT


Every dollar supports our mission delivery.

Goal $400,000

PLANNING FOR A SUSTAINABLE FUTURE

SARC has been the fortunate recipient of program-related, restricted funding.  But, our ability to continue to oversee the operations of these programs requires general operating support in the future. 

The lessons of the ongoing pandemic have shown that a solid infrastructure is necessary to weather current challenges so we can succeed in the face of future disruptors, and plan for a sustainable future. 

Approximately twenty-four percent of expenses incurred by SARC are not covered by grants and contracts, while seventy-six percent of our overall budget is allocated directly to programmatic endeavors.


PROGRAM 1

SARC CAREER DEVELOPMENT PROGRAM

Supports two awardees, including a second year of support contingent on scientific process.

Goal $400,000

Investing in the future of sarcoma research

Generally acknowledged as among SARC’s “Crown Jewels,” a core program of SARC has been to foster development of innovative research via the cultivation of the ideas and career paths of early-stage, young physicians/scientists dedicated to defeating sarcoma.

This program represents an essential and critical investment in scientific talent to advance research, an especially acute need for an uncommon cancer with limited career paths.

Past SARC award recipients are among today’s most productive sarcoma researchers, driving discoveries and translating innovations to the benefit of patients.


PROGRAM 2

INNOVATIVE CLINICAL TRIALS

Adding biomarker analyses to three open and soon to launch SARC-sponsored clinical trials.

Goal $200,00

ADVANCING CUTTING-EDGE APPROACHES

SARC has sponsored and launched 27 clinical trials since our founding.

Many of SARC’s more recent trials have included “correlative sciences,” which illuminates the relationship between the patients’ cancer cell biology (biomarkers) to disease progression or clinical responses. This is the promise of precision (or personalized) medicine. Unfortunately, limited trial budgets can curtail these highly informative, predictive studies.


PROGRAM 3

SARCOMA PATIENT ADVOCACY

Bringing the patient voice to research studies and scientific advances home to the patient community.

Goal $100,000

HOLISTICALLY SUPPORTING THE SARCOMA COMMUNITY

Sarcoma advocacy is integral to the mission of SARC and to our community, building awareness of sarcoma treatments, clinical trials, and resources that are available to help patients and families.

SARC’s Research Advocacy Council is an evolving, specially trained group of sarcoma survivors and caregivers. Our goal for 2022 and beyond is to assign a Research Advocate to each SARC clinical trial and so work side-by-side with the physicians adding the patient voice into study ideation and design – enabling more patient centric studies, increased enrollment, and greater impact.

Further, SARC intends to send Research Advocates to the major oncology/ sarcoma conferences. They will capture and then communicate (in lay language) promising scientific advances via SARC’s social media platforms – thus bringing hope and knowledge home to patients and their families.


PROGRAM 4

EDUCATION AND CONFERENCES

Funding for two SARC scientific conferences each year.

Goal $200,000

Fostering Collaboration Amongst the Scientific Community

One of the most effective ways to advance knowledge is to bring scientists together to share their work and findings.

SARC’s scientific/membership meetings have long provided forums for sarcoma collaborators to gather, present and discuss research, share insights and discoveries, spark ideas, and so inspire new directions for SARC and our collaborators to pursue.

  • June: American Society of Clinical Oncology (ASCO)
  • November: Connective Tissue Oncology Society (CTOS)

Convening hundreds of the leading sarcoma experts is essential in advancing SARC’s goals to better understand sarcoma and improve patient outcomes.


PROGRAM 5

TISSUE, CLINICAL DATA, AND IMAGING REPOSITORIES

Biospecimen Bank: Goal $200,000; Clinical Data Repository: GOAL $75,000; Imaging Repository: GOAL $35,000

Coordinating Vital Research Data

Biospecimen Bank
Our Biospecimen Bank is a “library” of sarcoma tissue and blood collected to explore biomarkers, identify novel therapeutic targets, and make other translational discoveries.

Currently, there are 20,000+ cancer tissue and blood samples available in “the library” used by sarcoma researchers to develop, test and validate concepts.

Imaging Repository
SARC has compiled all radiographic imaging studies from our clinical trials into a data imaging repository. This bank of images is linked to clinical data and available to all sarcoma investigators for further exploration and the generation of new ideas for sarcoma research.

Clinical Data Repository
SARC has established a vast clinical data repository of sarcoma research data sets which includes essential clinical trial data acquired over the years from SARC studies, contributed by thousands of patients.

This data is used by sarcoma researchers to develop new studies.

Back to top